Dyspnoea and exercise intolerance are near universal symptoms in fibrotic interstitial lung disease (fILD).1 Neither anti-fibrotic agents…

This symposium took place during the 2021 virtual meeting of the European Respiratory Society (ERS). It focused on improving the…

During the European Respiratory Society (ERS) International Congress 2021, speakers discussed the latest updates to the ERS…

Pneumomediastinum (PM) is a rare pathological entity that is divided into two categories: secondary, with a well-known aetiology, and…

As a medical student in Edinburgh, I was inspired by the opportunities in Edinburgh to combine clinical and basic science research in respiratory medicine.

I have always been incredibly interested in science and in trying to understand how things work. My first degree was in natural sciences at Cambridge, UK, where I specialised in neurobiology, and this exposed me to the beauty and rigor of basic science.

Vaccination is currently the most powerful tool for controlling the COVID-19 pandemic.1 In large randomised controlled trials, the approved vaccines have shown good efficacy and safety.2 However, there is increasing concern about the safety of the adenovirus-based COVID-19 vaccines of AstraZeneca (ChAdOx1 nCoV-19) and Janssen (Ad26.COV2.S).

The World Health Organization (WHO) has reported that an estimated 10.0 million people (range: 8.9–11.0 million) became ill with tuberculosis (TB) in 2019. There were an estimated 1.2 million TB deaths (range: 1.1–1.3 million) among people who were HIV-negative in 2019 and an additional 208,000 deaths (range: 177,000–242,000) among people who were HIV-positive.

EXPOSURE to air pollution and road traffic noise could increase the risk of developing heart failure. While previous research has shown a correlation between cardiovascular disease and air pollution, this new study has revealed that noise pollution may also increase incidence.

RESEARCHERS at the Washington University School of Medicine, St. Louis, USA have demonstrated that high levels of circulating fatty acid synthase (cFAS) in the blood could be used to detect a severe type of peripheral artery disease caused by narrowing arteries in the legs, which could increase the risk of developing a heart attack or a stroke. Current healthcare professionals use blood pressure, cholesterol levels, and blood sugar to evaluate cardiovascular health. Unfortunately, there are no accurate blood tests to precisely detect the risk of artery narrowing or blockage.